Not all unicorns earn their billion-dollar valuations creating the next big app. Some unicorns actually make real things.» Read More
What follows is a roundup of corporate earnings reports for Thursday, Feb. 11
Retail sales, at down 0.3 percent, was below expectations of a gain of 0.5 percent, though November was revised upward, while first time unemployment claims rose slightly more than expected for the week.
Specialist business continues to consolidate: LaBranche trades up 30 percent after the close, in a deal that makes Barclay's designated market maker unit the largest DMM at the NYSE.
Specialist firm LaBranche halted for News Pending. Rumors that the firm has been for sale has been around for months now....
It appears that Washington is about to enact sweeping legislation that will be the greatest shift in public policy in decades. Yes, we can bemoan the lack of a completely private enterprise driven system but the reality is Big Brother is here and he's not going away. Without a doubt there will be implications for investors that need to be considered; and it's not all bad news from an investment perspective.
Warren Buffett agreed to buy one of America’s largest railroad companies in a deal valued at $44 billion. So what does Buffett’s move say about investing in America right now? David Pearl, co-CIO of Epoch Investment Partners, shared his insights.
Considering investors stepped into this market and bid shares higher even with unemployment at a 26-year high, is it safe to assume the bulls are back?
Critics have been saying for years that big pharma's been pi..., er, throwing away money on relatively unproductive research and development of new drugs. But a new study shows urine could eventually provide a new revenue stream.
Companies that provide laboratory services are down late in the day on talk that the the new Senate Finance Committee bill on healthcare will contain a co-pay for labs that will save some $20 billion over 10 years, which may put pressure on profits of those companies.
Unemployment hit 8.9 percent in April and some predict that number could climb to over 10 percent in 2009. But how far can this streamlining really go? See the S&P 500's leanest companies.
David Pearl of Epoch Investment Partners and David Moon of Moon Capital Management offered CNBC their insights. (Part 1: Medical Services)
Cramer makes the call on viewers' favorite stocks.
With stocks sharply lower today, shareholders need to protect their portfolios. So what are some of the best defensive stock picks? CNBC asked the experts.
Comcast, Lab Corp., Zimmer Holdings and others are all down today, but the still the market rallies. Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Recent spikes in Quest Diagnostics's stock price suggest the No. 1 medical testing company could be the latest buyout target in health care, but its valuation and debt load may keep private equity bidders at bay.
Specialist trading company LaBranche on Monday said it will review strategic alternatives for the business and said it expects a second-quarter loss.
The parent of the New York Stock Exchange has been accused in a $4 billion lawsuit of providing worse prices on trades executed through its electronic SuperDOT system than those handled by floor traders.
Cramer goes through the mailbag, answering questions about IPOs, oil service companies and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
As far as Cramer is concerned, the Sirius-XM Satellite Radio proposed deal is just the first of many coming over the next two years as corporations race to beat a potential Democratic White House in 2008. But which companies are in the best poised to profit?